1
|
Gestational hypertension and preeclampsia in living kidney donors.
|
N Engl J Med
|
2014
|
7.25
|
2
|
Desensitization in HLA-incompatible kidney recipients and survival.
|
N Engl J Med
|
2011
|
6.72
|
3
|
Association of race and age with survival among patients undergoing dialysis.
|
JAMA
|
2011
|
5.82
|
4
|
Frailty as a predictor of surgical outcomes in older patients.
|
J Am Coll Surg
|
2010
|
5.72
|
5
|
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.
|
N Engl J Med
|
2015
|
5.03
|
6
|
Lifetime incidence of CKD stages 3-5 in the United States.
|
Am J Kidney Dis
|
2013
|
3.82
|
7
|
Sarcopenia and mortality after liver transplantation.
|
J Am Coll Surg
|
2010
|
2.75
|
8
|
Domino paired kidney donation: a strategy to make best use of live non-directed donation.
|
Lancet
|
2006
|
2.38
|
9
|
Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.
|
Transplantation
|
2014
|
2.26
|
10
|
Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation.
|
JAMA
|
2005
|
2.15
|
11
|
Estimates of early death, acute liver failure, and long-term mortality among live liver donors.
|
Gastroenterology
|
2011
|
2.07
|
12
|
Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis.
|
J Am Geriatr Soc
|
2013
|
2.06
|
13
|
Candidacy for kidney transplantation of older adults.
|
J Am Geriatr Soc
|
2012
|
1.85
|
14
|
Center-level factors and racial disparities in living donor kidney transplantation.
|
Am J Kidney Dis
|
2012
|
1.82
|
15
|
Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study.
|
Hepatology
|
2007
|
1.82
|
16
|
A nonsimultaneous, extended, altruistic-donor chain.
|
N Engl J Med
|
2009
|
1.81
|
17
|
The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation.
|
Liver Transpl
|
2011
|
1.79
|
18
|
Caroli's disease and outcomes after liver transplantation.
|
Liver Transpl
|
2008
|
1.78
|
19
|
Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients.
|
Transplantation
|
2012
|
1.78
|
20
|
ABO incompatible renal transplantation: a paradigm ready for broad implementation.
|
Transplantation
|
2009
|
1.71
|
21
|
Patient attitudes toward CDC high infectious risk donor kidney transplantation: inferences from focus groups.
|
Clin Transplant
|
2011
|
1.64
|
22
|
Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation.
|
Transplantation
|
2014
|
1.62
|
23
|
Live donor champion: finding live kidney donors by separating the advocate from the patient.
|
Transplantation
|
2012
|
1.60
|
24
|
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.
|
J Infect Dis
|
2010
|
1.58
|
25
|
Cumulative incidence of cancer after solid organ transplantation.
|
Cancer
|
2013
|
1.58
|
26
|
Outcomes of ABO-incompatible kidney transplantation in the United States.
|
Transplantation
|
2012
|
1.55
|
27
|
Trends in kidney transplant outcomes in older adults.
|
J Am Geriatr Soc
|
2014
|
1.53
|
28
|
Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis.
|
Liver Transpl
|
2012
|
1.52
|
29
|
Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States.
|
Liver Transpl
|
2007
|
1.51
|
30
|
Race, Relationship and Renal Diagnoses After Living Kidney Donation.
|
Transplantation
|
2015
|
1.45
|
31
|
Living kidney donors ages 70 and older: recipient and donor outcomes.
|
Clin J Am Soc Nephrol
|
2011
|
1.45
|
32
|
Impact of broader sharing on the transport time for deceased donor livers.
|
Liver Transpl
|
2014
|
1.41
|
33
|
Effect of eliminating priority points for HLA-B matching on racial disparities in kidney transplant rates.
|
Am J Kidney Dis
|
2011
|
1.41
|
34
|
The impact of nonidentical ABO deceased donor kidney transplant on kidney utilization.
|
Am J Kidney Dis
|
2010
|
1.39
|
35
|
Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts.
|
Transplantation
|
2008
|
1.35
|
36
|
The interplay of socioeconomic status, distance to center, and interdonor service area travel on kidney transplant access and outcomes.
|
Clin J Am Soc Nephrol
|
2010
|
1.32
|
37
|
A comparison of populations served by kidney paired donation and list paired donation.
|
Am J Transplant
|
2005
|
1.32
|
38
|
Frailty and delayed graft function in kidney transplant recipients.
|
Arch Surg
|
2012
|
1.30
|
39
|
Living unrelated renal transplantation: a good match for the pediatric candidate?
|
J Pediatr Surg
|
2013
|
1.30
|
40
|
Kidney transplantation in the elderly.
|
Semin Nephrol
|
2009
|
1.27
|
41
|
Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension.
|
Clin Gastroenterol Hepatol
|
2007
|
1.25
|
42
|
Vascular disease, ESRD, and death: interpreting competing risk analyses.
|
Clin J Am Soc Nephrol
|
2012
|
1.23
|
43
|
Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors.
|
Transplantation
|
2014
|
1.22
|
44
|
Liver sharing and organ procurement organization performance.
|
Liver Transpl
|
2015
|
1.21
|
45
|
Factors affecting graft survival after liver transplantation from donation after cardiac death donors.
|
Transplantation
|
2006
|
1.14
|
46
|
Robust Models Support Redistricting Liver Allocation to Reduce Geographic Disparity.
|
Transplantation
|
2015
|
1.12
|
47
|
Understanding surgical decision making in early hepatocellular carcinoma.
|
J Clin Oncol
|
2011
|
1.12
|
48
|
National trends over 25 years in pediatric kidney transplant outcomes.
|
Pediatrics
|
2014
|
1.11
|
49
|
Trends in the timing of pre-emptive kidney transplantation.
|
J Am Soc Nephrol
|
2011
|
1.10
|
50
|
Kidney paired donation: fundamentals, limitations, and expansions.
|
Am J Kidney Dis
|
2011
|
1.06
|
51
|
C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.
|
J Am Soc Nephrol
|
2008
|
1.04
|
52
|
Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients.
|
Transplantation
|
2014
|
1.04
|
53
|
Renal transplant in HIV-positive patients: long-term outcomes and risk factors for graft loss.
|
Arch Surg
|
2009
|
1.04
|
54
|
National trends in surgical procedures for hepatocellular carcinoma: 1998-2008.
|
Cancer
|
2011
|
1.04
|
55
|
Age at graft loss after pediatric kidney transplantation: exploring the high-risk age window.
|
Clin J Am Soc Nephrol
|
2013
|
1.03
|
56
|
Arteriosclerosis in kidneys from healthy live donors: comparison of wedge and needle core perioperative biopsies.
|
Arch Pathol Lab Med
|
2008
|
0.99
|
57
|
Increasing the pool of deceased donor organs for kidney transplantation.
|
Nat Rev Nephrol
|
2012
|
0.98
|
58
|
Incompatible live-donor kidney transplantation in the United States: results of a national survey.
|
Clin J Am Soc Nephrol
|
2011
|
0.97
|
59
|
Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells.
|
Mol Cell Endocrinol
|
2003
|
0.96
|
60
|
New options for patients with donor incompatibilities.
|
Transplantation
|
2006
|
0.96
|
61
|
Practice patterns and outcomes in retransplantation among pediatric kidney transplant recipients.
|
Transplantation
|
2013
|
0.95
|
62
|
The diagnosis of acute appendicitis in a pediatric population: to CT or not to CT.
|
J Pediatr Surg
|
2003
|
0.92
|
63
|
National assessment of early biliary complications following liver transplantation: incidence and outcomes.
|
Liver Transpl
|
2014
|
0.91
|
64
|
Preemptive deceased donor kidney transplantation: considerations of equity and utility.
|
Clin J Am Soc Nephrol
|
2013
|
0.91
|
65
|
Association of antibody induction immunosuppression with cancer after kidney transplantation.
|
Transplantation
|
2015
|
0.90
|
66
|
Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipients.
|
J Am Soc Nephrol
|
2008
|
0.90
|
67
|
The utility of TIPS in the management of Budd-Chiari syndrome.
|
Ann Surg
|
2005
|
0.90
|
68
|
Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma.
|
Ann Surg Oncol
|
2012
|
0.89
|
69
|
Clinical Trials for Immunosuppression in Transplantation; The Case for Reform and Change in Direction.
|
Transplantation
|
2017
|
0.87
|
70
|
Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
|
Liver Transpl
|
2009
|
0.87
|
71
|
Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims data.
|
Am J Nephrol
|
2014
|
0.86
|
72
|
Order of donor type in pediatric kidney transplant recipients requiring retransplantation.
|
Transplantation
|
2013
|
0.86
|
73
|
Increased risk of graft loss from hepatic artery thrombosis after liver transplantation with older donors.
|
Liver Transpl
|
2009
|
0.86
|
74
|
Health outcomes among non-Caucasian living kidney donors: knowns and unknowns.
|
Transpl Int
|
2013
|
0.85
|
75
|
Potential limitations of presumed consent legislation.
|
Transplantation
|
2012
|
0.85
|
76
|
The high-risk donor: viral infections in solid organ transplantation.
|
Curr Opin Organ Transplant
|
2008
|
0.85
|
77
|
Outcomes of Live Kidney Donors Who Develop End-Stage Renal Disease.
|
Transplantation
|
2016
|
0.84
|
78
|
Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
|
Transplantation
|
2016
|
0.84
|
79
|
Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients.
|
Transplantation
|
2015
|
0.84
|
80
|
Activity of daily living disability and dialysis mortality: better prediction using metrics of aging.
|
J Am Geriatr Soc
|
2012
|
0.84
|
81
|
Cancer risk after ABO-incompatible living-donor kidney transplantation.
|
Transplantation
|
2013
|
0.84
|
82
|
Successful transplantation of cadaveric polycystic liver: case report and review of the literature.
|
Transplantation
|
2006
|
0.84
|
83
|
Mullerian inhibiting substance regulates androgen-induced gene expression and growth in prostate cancer cells through a nuclear factor-kappaB-dependent Smad-independent mechanism.
|
Mol Endocrinol
|
2006
|
0.83
|
84
|
Provider response to a rare but highly publicized transmission of HIV through solid organ transplantation.
|
Arch Surg
|
2011
|
0.83
|
85
|
Recipient age and time spent hospitalized in the year before and after kidney transplantation.
|
Transplantation
|
2012
|
0.83
|
86
|
Sirolimus based immunosuppression is associated with need for early repeat therapeutic ERCP in liver transplant patients with anastomotic biliary stricture.
|
Ann Hepatol
|
2013
|
0.82
|
87
|
Kidney Transplants from HLA-Incompatible Live Donors and Survival.
|
N Engl J Med
|
2016
|
0.82
|
88
|
Surgical management of early and late ureteral complications after renal transplantation: techniques and outcomes.
|
Clin Transplant
|
2014
|
0.82
|
89
|
Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants.
|
Transplantation
|
2014
|
0.81
|
90
|
Renal Transplantation in HIV-Positive Recipients.
|
Curr Infect Dis Rep
|
2010
|
0.81
|
91
|
Survival Benefit of Kidney Transplantation in HIV-infected Patients.
|
Ann Surg
|
2016
|
0.81
|
92
|
Better understanding live donor risk through big data.
|
Clin J Am Soc Nephrol
|
2013
|
0.81
|
93
|
Role of MDCT angiography in selection and presurgical planning of potential renal donors.
|
AJR Am J Roentgenol
|
2012
|
0.81
|
94
|
Gout after living kidney donation: correlations with demographic traits and renal complications.
|
Am J Nephrol
|
2015
|
0.80
|
95
|
High infectious risk donors: what are the risks and when are they too high?
|
Curr Opin Organ Transplant
|
2011
|
0.80
|
96
|
Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients.
|
Am J Kidney Dis
|
2012
|
0.80
|
97
|
Center-level variation in the development of delayed graft function after deceased donor kidney transplantation.
|
Transplantation
|
2015
|
0.80
|
98
|
HLA incompatible renal transplantation.
|
Curr Opin Organ Transplant
|
2012
|
0.80
|
99
|
National assessment of early biliary complications after liver transplantation: economic implications.
|
Transplantation
|
2014
|
0.79
|
100
|
Volumes of liver transplant and partial hepatectomy procedures are independently associated with lower postoperative mortality following resection for hepatocellular carcinoma.
|
Liver Transpl
|
2009
|
0.79
|
101
|
Where the Sun Shines: Industry's Payments to Plastic Surgeons.
|
Plast Reconstr Surg
|
2015
|
0.79
|
102
|
International kidney paired donation.
|
Transplantation
|
2013
|
0.79
|
103
|
The fate of anti-HLA antibody among renal transplantation recipients treated with bortezomib.
|
Clin Transpl
|
2009
|
0.79
|
104
|
ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysis.
|
Liver Transpl
|
2009
|
0.79
|
105
|
Outcomes of renal transplants from Centers for Disease Control and Prevention high-risk donors with prospective recipient viral testing: a single-center experience.
|
Arch Surg
|
2011
|
0.78
|
106
|
Outcomes of liver transplantation for glycogen storage disease: a matched-control study and a review of literature.
|
Clin Transplant
|
2011
|
0.78
|
107
|
New developments in geriatric surgery.
|
Curr Probl Surg
|
2011
|
0.78
|
108
|
Patterns of Kidney Function Before and After Orthotopic Liver Transplant: Associations With Length of Hospital Stay, Progression to End-Stage Renal Disease, and Mortality.
|
Transplantation
|
2015
|
0.78
|
109
|
Survey of North American pathologist practices regarding antibody-mediated rejection in cardiac transplant biopsies.
|
Cardiovasc Pathol
|
2010
|
0.78
|
110
|
Race is a predictor of in-hospital mortality after cholecystectomy, especially in those with portal hypertension.
|
Clin Gastroenterol Hepatol
|
2008
|
0.78
|
111
|
Late graft loss among pediatric recipients of DCD kidneys.
|
Clin J Am Soc Nephrol
|
2011
|
0.78
|
112
|
Age and sex disparities in discussions about kidney transplantation in adults undergoing dialysis.
|
J Am Geriatr Soc
|
2014
|
0.77
|
113
|
From Bench to Bill: How a Transplant Nuance Became 1 of Only 57 Laws Passed in 2013.
|
Ann Surg
|
2016
|
0.77
|
114
|
Blood dendritic cell levels associated with impaired IL-12 production and T-cell deficiency in patients with kidney disease: implications for post-transplant viral infections.
|
Transpl Int
|
2014
|
0.77
|
115
|
Operative start times and complications after kidney transplantation.
|
Clin Transplant
|
2012
|
0.77
|
116
|
Living donor kidney exchange.
|
Clin Transpl
|
2011
|
0.77
|
117
|
Actual and perceived knowledge of kidney transplantation and the pursuit of a live donor.
|
Transplantation
|
2014
|
0.77
|
118
|
Outcomes and discard of kidneys from pediatric donors after cardiac death.
|
Transplantation
|
2011
|
0.76
|
119
|
Translational research in surgical disease.
|
Arch Surg
|
2010
|
0.76
|
120
|
HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience.
|
Ann Transplant
|
2013
|
0.76
|
121
|
Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation.
|
Transplantation
|
2016
|
0.76
|
122
|
Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.
|
Liver Transpl
|
2015
|
0.76
|
123
|
The application of paired donation to live donor liver transplantation.
|
Liver Transpl
|
2010
|
0.76
|
124
|
Virtual populations, real decisions: making sense of stochastic simulation studies.
|
Transplantation
|
2015
|
0.75
|
125
|
Diabetes Mellitus in Living Pancreas Donors: Use of Integrated National Registry and Pharmacy Claims Data to Characterize Donation-Related Health Outcomes.
|
Transplantation
|
2016
|
0.75
|
126
|
Living kidney donors and their family caregivers: developing an evidence-based educational and social support website.
|
Prog Transplant
|
2012
|
0.75
|
127
|
The Dawn of Transparency: Insights from the Physician Payment Sunshine Act in Plastic Surgery.
|
Ann Plast Surg
|
2017
|
0.75
|
128
|
Fast-tracking and fairness: getting organ offers quickly to candidates who will accept them.
|
Liver Transpl
|
2013
|
0.75
|
129
|
Transplantation: Alloantibodies in simultaneous liver-kidney transplantation.
|
Nat Rev Nephrol
|
2013
|
0.75
|
130
|
The authors' reply.
|
Transplantation
|
2014
|
0.75
|
131
|
Individual Frailty Components and Mortality In Kidney Transplant Recipients.
|
Transplantation
|
2016
|
0.75
|
132
|
Clinical and Economic Consequences of Early Cancer after Kidney Transplantation in Contemporary Practice.
|
Transplantation
|
2016
|
0.75
|
133
|
Long-term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation.
|
Transplantation
|
2016
|
0.75
|
134
|
Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients: A National Registry and Prospective Cohort Study.
|
Ann Surg
|
2016
|
0.75
|
135
|
Influencing public policy to improve the lives of older Americans.
|
Gerontologist
|
2010
|
0.75
|
136
|
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.
|
Transplantation
|
2017
|
0.75
|
137
|
Mortality and Graft Loss Attributable to Readmission following Kidney Transplantation: Immediate and Long-Term Risk.
|
Transplantation
|
2016
|
0.75
|
138
|
Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.
|
Ann Surg
|
2017
|
0.75
|
139
|
Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants.
|
Transplantation
|
2017
|
0.75
|
140
|
The Right Organ for the Right Recipient: the Ninth Annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium.
|
Clin Transplant
|
2011
|
0.75
|
141
|
A New Culture of Transparency: Industry Payments to Orthopedic Surgeons.
|
Orthopedics
|
2016
|
0.75
|
142
|
Deceased-donor liver size and the sex-based disparity in liver transplantation.
|
Transplantation
|
2017
|
0.75
|
143
|
Impact of Race and Ethnicity on Outcomes for Children Waitlisted for Pediatric Liver Transplantation.
|
J Pediatr Gastroenterol Nutr
|
2017
|
0.75
|
144
|
Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.
|
Transplantation
|
2017
|
0.75
|
145
|
Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35.
|
Transplantation
|
2019
|
0.75
|
146
|
Baseline and Center-Level Variation in Simultaneous Liver-Kidney Listing in the United States.
|
Transplantation
|
2017
|
0.75
|
147
|
Frailty and Postkidney Transplant Health-Related Quality of Life.
|
Transplantation
|
2017
|
0.75
|
148
|
Survey of current practice related to grading of rejection in cardiac transplant recipients in North America.
|
Cardiovasc Pathol
|
2010
|
0.75
|
149
|
Controversies in kidney paired donation.
|
Adv Chronic Kidney Dis
|
2012
|
0.75
|